These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10585784)

  • 21. Outpatient parenteral antibiotic therapy in Singapore.
    Fisher DA; Kurup A; Lye D; Tambyah PA; Sulaiman Z; Poon EY; Lee W; Kaur V; Lim PL
    Int J Antimicrob Agents; 2006 Dec; 28(6):545-50. PubMed ID: 17097856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central nervous system infections as a cause of an altered mental status? What is the pathogen growing in your central nervous system?
    Mace SE
    Emerg Med Clin North Am; 2010 Aug; 28(3):535-70. PubMed ID: 20709243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developments in outpatient parenteral antimicrobial therapy (OPAT) for Gram-positive infections in Europe, and the potential impact of daptomycin.
    Nathwani D
    J Antimicrob Chemother; 2009 Sep; 64(3):447-53. PubMed ID: 19584105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.
    Yong C; Fisher DA; Sklar GE; Li SC
    Int J Antimicrob Agents; 2009 Jan; 33(1):46-51. PubMed ID: 18823759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outpatient parenteral antimicrobial therapy today.
    Paladino JA; Poretz D
    Clin Infect Dis; 2010 Sep; 51 Suppl 2():S198-208. PubMed ID: 20731577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal non-typhoidal Salmonella infections from a single center in Malaysia.
    Lee WS; Hafeez A; Hassan H; Raja NS; Puthucheary SD
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):678-82. PubMed ID: 16124437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mandatory infectious diseases approval of outpatient parenteral antimicrobial therapy (OPAT): clinical and economic outcomes of averted cases.
    Conant MM; Erdman SM; Osterholzer D
    J Antimicrob Chemother; 2014 Jun; 69(6):1695-700. PubMed ID: 24532684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher occurrence of hepatotoxicity and rash in patients treated with oxacillin, compared with those treated with nafcillin and other commonly used antimicrobials.
    Maraqa NF; Gomez MM; Rathore MH; Alvarez AM
    Clin Infect Dis; 2002 Jan; 34(1):50-4. PubMed ID: 11731945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic.
    Suleyman G; Kenney R; Zervos MJ; Weinmann A
    J Clin Pharm Ther; 2017 Feb; 42(1):39-43. PubMed ID: 27747899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Home intravenous antibiotic therapy for osteomyelitis patients].
    Steinmetz D; Edelstein H; Berkovits E; Raz R
    Harefuah; 2002 May; 141(5):439-41, 498. PubMed ID: 12073523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting.
    White HA; Davis JS; Kittler P; Currie BJ
    Intern Med J; 2011 Sep; 41(9):668-73. PubMed ID: 20002854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experience with linezolid therapy in children with osteoarticular infections.
    Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
    Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced aseptic meningitis in suspected central nervous system infections.
    Kepa L; Oczko-Grzesik B; Stolarz W; Sobala-Szczygiel B
    J Clin Neurosci; 2005 Jun; 12(5):562-4. PubMed ID: 16051094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy.
    Lacroix A; Revest M; Patrat-Delon S; Lemaître F; Donal E; Lorléac'h A; Arvieux C; Michelet C; Tattevin P
    Med Mal Infect; 2014 Jul; 44(7):327-30. PubMed ID: 25022891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives on interactions between antiepileptic drugs (AEDs) and antimicrobial agents.
    Desai J
    Epilepsia; 2008 Aug; 49 Suppl 6():47-9. PubMed ID: 18754961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update and overview of outpatient parenteral antimicrobial therapy regulations and reimbursement.
    Ross Nolet B
    Clin Infect Dis; 2010 Sep; 51 Suppl 2():S216-9. PubMed ID: 20731579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with 211 courses of home intravenous antimicrobial therapy.
    Baptista RJ; Mitrano FP
    Am J Hosp Pharm; 1989 Feb; 46(2):315-6. PubMed ID: 2712055
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.
    Lamont E; Seaton RA; Macpherson M; Semple L; Bell E; Thomson AH
    J Antimicrob Chemother; 2009 Jul; 64(1):181-7. PubMed ID: 19411678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use and misuse of antimicrobial agents in a general hospital in the AIDS era.
    Rivero M; Padilla B; García-Lechuz J; Cruz Menárguez M; Rodríguez-Créixems M; Bouza E
    J Hosp Infect; 2000 Nov; 46(3):230-5. PubMed ID: 11073733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.